Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0551 USD | 0.00% | -5.97% | +48.92% |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Apr. 11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 8.59M |
---|---|---|---|---|---|
Net income 2021 | -17M | Net income 2022 | -19M | EV / Sales 2021 | - |
Net cash position 2021 | 23.78M | Net cash position 2022 | 6.72M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.66
x | P/E ratio 2022 |
-0.43
x | Employees | 18 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.97% |
Latest transcript on Bellerophon Therapeutics, Inc.
1 week | -5.97% | ||
Current month | -2.99% | ||
1 month | -0.90% | ||
3 months | +0.18% | ||
6 months | +46.93% | ||
Current year | +48.92% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 15-01-28 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 15-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.0551 | 0.00% | 842 |
24-04-29 | 0.0551 | -0.54% | 8,148 |
24-04-26 | 0.0554 | +0.73% | 17,511 |
24-04-25 | 0.055 | +1.66% | 10,136 |
24-04-24 | 0.0541 | -7.68% | 47,040 |
Delayed Quote OTC Markets, April 30, 2024 at 09:33 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+48.92% | 674K | |
-2.80% | 102B | |
+1.92% | 96.29B | |
+2.04% | 22.18B | |
-15.53% | 21.2B | |
-9.00% | 18.31B | |
-38.74% | 17.38B | |
-13.46% | 16.36B | |
+6.24% | 13.97B | |
+34.32% | 12.17B |
- Stock Market
- Equities
- BLPH Stock